Talphera, Inc. Common Stock
Symbol: TLPH (NASDAQ)
1.17
▼ (-1.27%) -0.015
Company Description:
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Key Stats
- Today's Open: $1.17
- Today's High: $1.175
- Today's Low: $1.121
- Today's Volume: 33.53K
- Yesterday Close: $1.18
- Yesterday High: $1.19
- Yesterday Low: $1.08
- Yesterday Volume: 285.35K
- Last Min Volume: 30
- Last Min High: $1.165
- Last Min Low: $1.165
- Last Min VWAP: $1.165
Company Profile
- Name: Talphera, Inc. Common Stock
- Website: https://www.talphera.com
- Listed Date: 2011-02-11
- Location: SAN MATEO, CA
- Market Status: Active
- CIK Number: 0001427925
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $51.51M
- Round Lot: 100
- Outstanding Shares: 45.59M
- Asset Type: CS
RECENT FILINGS FOR TLPH
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-22 | 8-K | View |
| 2025-10-16 | 4 | View |
| 2025-10-16 | 3 | View |
| 2025-10-16 | 8-K | View |
| 2025-09-29 | EFFECT | View |
| 2025-09-29 | 424B7 | View |
| 2025-09-24 | ARS | View |
| 2025-09-22 | S-3 | View |
| 2025-09-16 | SCHEDULE 13G | View |
| 2025-09-15 | D | View |
| 2025-09-12 | 3 | View |
| 2025-09-12 | SCHEDULE 13D | View |
| 2025-09-12 | SCHEDULE 13G | View |
| 2025-09-10 | 8-K | View |
| 2025-09-09 | DEFA14A | View |
| 2025-09-09 | DEF 14A | View |
| 2025-08-29 | PRE 14A | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-06-05 | 8-K | View |
Latest News on TLPH